AFX: atypical fibroxanthoma dVIN: differentiated-type vulvar intraepithelial neoplasia UPS: undifferentiated pleomorphic sarcoma INTRODUCTION The term atypical fibroxanthoma (AFX) was first used in 1963 by Helwig et al to indicate a… Click to show full abstract
AFX: atypical fibroxanthoma dVIN: differentiated-type vulvar intraepithelial neoplasia UPS: undifferentiated pleomorphic sarcoma INTRODUCTION The term atypical fibroxanthoma (AFX) was first used in 1963 by Helwig et al to indicate a typically nodular ulcerative tumor arising on sun-exposed skin of the head and neck of the elderly. Furthermore, AFX has been described after radiation therapy and in immunosuppressed patients, specifically in transplant patients or in HIV-positive patients. A diagnosis of AFX requires most caution, because it implies a biologically benign lesion that must be differentiated from malignant cutaneous tumors. Here we underline the problems of differential diagnosis and therapeutic management of AFX in a previously unrecognized site, providing a description of its clinical and pathologic features, which could assist both the clinician and pathologist in avoiding misdiagnosis and relative unnecessary treatment.
               
Click one of the above tabs to view related content.